Imminent U.S.-China Trade Talks Boosts Futures
Stock futures advanced Wednesday as investors monitored the latest updates on U.S. trade negotiations and looked toward the Federal Reserve interest rate announcement expected later in the day.Futures for the Dow Jones Industrials popped 308 points, or 0.8% to 41,224.Futures for the S&P 500 index spiked 39.75 points, or 0.7%, to 5,665.50Futures for the NASDAQ jumped 144.5 points, or 0.7%, to 20,021.Tuesday night’s moves follow a losing day on Wall Street. The Dow lost nearly 390 points, or 1%. The S&P 500 docked about 0.8% and NASDAQ slid about 0.9%. Futures took a leg up on news that U.S. Treasury Secretary Scott Bessent and top trade official Jamieson Greer would meet with their Chinese counterparts this week in Switzerland. Investors took that as a positive on the trade front after the turbulent market action following President Donald Trump’s tariff announcement last month.That action comes as investors gear up for the Fed’s interest rate decision slated for 2 p.m. ET. Fed funds futures are pricing in a nearly 97% likelihood that the central bank holds the borrowing rate steady.In Japan, the Nikkei 225 index sank 0.1%, while in Hong Kong, the Hang Seng crept up 0.1%. Oil prices acquired 50 cents to $59.59 U.S. a barrel. Gold prices slipped $27.60 to $3,395.20 U.S. an ounce.
Recent Posts

Romanian Inflation Ends Tumultuous Year in Politics Close to 10%

UK Boosts Support For Offshore Wind in Bumper Auction

Ireland Is Trying to Get Back on the Data Center Bandwagon

Notice Concerning Change of Representative Executive Officer

Polish Recycler Bets Millions on Europe’s Critical Metals Push

Blistering Metals Rally Sends Silver, Tin and Copper to Records

Wellington Management Appoints Alex Behm to Strengthen Secondaries Capabilities

TCS and AMD Announce Strategic Collaboration to Drive AI Adoption at Scale

New data reinforces Ipsen’s commitment to bringing solutions and addressing care gaps in neurological diseases at TOXINS

TOXINS 2026: Clinical Updates on Galderma’s Leading Neuromodulator Portfolio Further Reinforce Its Leadership in Injectable Aesthetics


